UBS Group’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.6K Sell
22,813
-2,966
-12% -$5.93K ﹤0.01% 6557
2025
Q1
$64.4K Sell
25,779
-106,535
-81% -$266K ﹤0.01% 6107
2024
Q4
$390K Buy
132,314
+122,193
+1,207% +$360K ﹤0.01% 4856
2024
Q3
$30.5K Sell
10,121
-9,145
-47% -$27.5K ﹤0.01% 5920
2024
Q2
$67K Buy
19,266
+14,530
+307% +$50.6K ﹤0.01% 5315
2024
Q1
$25K Buy
4,736
+4,619
+3,948% +$24.4K ﹤0.01% 5649
2023
Q4
$601 Sell
117
-1,381
-92% -$7.09K ﹤0.01% 7361
2023
Q3
$7.85K Buy
1,498
+1,381
+1,180% +$7.24K ﹤0.01% 6071
2023
Q2
$219 Sell
117
-6,459
-98% -$12.1K ﹤0.01% 7288
2023
Q1
$24.7K Buy
6,576
+488
+8% +$1.83K ﹤0.01% 5837
2022
Q4
$18.3K Buy
+6,088
New +$18.3K ﹤0.01% 6569
2022
Q3
Sell
-782
Closed -$21K 9732
2022
Q2
$21K Buy
782
+351
+81% +$9.43K ﹤0.01% 5795
2022
Q1
$16K Sell
431
-14,462
-97% -$537K ﹤0.01% 6716
2021
Q4
$871K Buy
14,893
+7,786
+110% +$455K ﹤0.01% 3544
2021
Q3
$585K Buy
7,107
+7,099
+88,738% +$584K ﹤0.01% 3628
2021
Q2
$1K Sell
8
-352
-98% -$44K ﹤0.01% 8083
2021
Q1
$23K Sell
360
-310
-46% -$19.8K ﹤0.01% 6231
2020
Q4
$39K Sell
670
-6
-0.9% -$349 ﹤0.01% 5410
2020
Q3
$14K Sell
676
-1,908
-74% -$39.5K ﹤0.01% 5722
2020
Q2
$41K Buy
2,584
+1,629
+171% +$25.8K ﹤0.01% 5203
2020
Q1
$13K Buy
955
+285
+43% +$3.88K ﹤0.01% 5877
2019
Q4
$14K Sell
670
-159
-19% -$3.32K ﹤0.01% 6030
2019
Q3
$27K Buy
829
+312
+60% +$10.2K ﹤0.01% 5592
2019
Q2
$11K Buy
+517
New +$11K ﹤0.01% 6155
2019
Q1
Sell
-278
Closed -$13K 7144
2018
Q4
$13K Sell
278
-92
-25% -$4.3K ﹤0.01% 6181
2018
Q3
$16K Buy
+370
New +$16K ﹤0.01% 6017
2018
Q2
Sell
-443
Closed -$12K 7174
2018
Q1
$12K Buy
+443
New +$12K ﹤0.01% 5883
2017
Q4
Sell
-6
Closed 6994
2017
Q3
$0 Sell
6
-197
-97% ﹤0.01% 6913
2017
Q2
$11K Buy
+203
New +$11K ﹤0.01% 5784
2017
Q1
Sell
-35
Closed -$4K 6840
2016
Q4
$4K Buy
35
+9
+35% +$1.03K ﹤0.01% 6357
2016
Q3
$3K Buy
+26
New +$3K ﹤0.01% 6363